Physician

William S Jonas, M.D.

According to 2025 Medicare claims, William Jonas, M.D. (NPI: 1962443051) practices hematology/oncology in the Atlanta-Sandy Springs-Roswell, GA market, with the plurality of this provider's patient population coming from Fulton, GA. This provider's primary affiliated billing organization is PIEDMONT CANCER INSTITUTE PC (NPI: 1336180637; TIN: 581761689) and primary practice location at 30318-0922. Jonas is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Jonas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 832 traditional Medicare patients, billed 170,551 HCPCS/CPT codes, and received $3,782,939 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,166 prescription claims across 347 beneficiaries totaling $6,442,953 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 83 claims. Open Payments data shows 71 records totaling $1,694. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,421,201 to $3,782,939. Similarly, Part D prescription costs have moved sharply higher in recent years, from $863,628 to $6,442,953. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $20,334 to $2,331.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	694	82,327	$1,421,201
2016	800	117,190	$1,757,588
2017	854	138,284	$1,816,552
2018	811	160,055	$2,224,717
2019	714	164,407	$2,801,379
2020	710	146,986	$3,334,217
2021	722	184,964	$3,602,045
2022	768	168,039	$3,798,204
2023	789	175,824	$3,739,598
2024	832	170,551	$3,782,939

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	240	1,545	$863,628
2016	237	1,405	$1,496,708
2017	243	1,689	$1,842,062
2018	264	1,862	$2,562,840
2019	258	1,908	$3,539,153
2020	264	1,820	$3,388,846
2021	280	2,122	$4,711,965
2022	300	2,002	$4,889,058
2023	332	2,141	$6,174,776
2024	347	2,166	$6,442,953

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	62	307	$20,597
2016	N/R	84	$24,060
2017	N/R	11	$1,007
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	16	$363
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	83	$2,210

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	120	120	$113
96413	Administration of chemotherapy into vein, 1 hour or less	98	506	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	172	285	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	571	1,090	$58
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	689	1,643	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	80	2,400	$1,345,339
Revlimid	Lenalidomide	62	1,680	$985,995
Imbruvica	Ibrutinib	50	1,402	$802,019
Brukinsa	Zanubrutinib	37	1,054	$512,323
Calquence	Acalabrutinib Maleate	35	1,050	$483,308

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	17	$750
J8521	Capecitabine, oral, 500 mg	N	N/R	16	$690
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	24	$433
K0001	Standard wheelchair	Y	N/R	13	$240
K0195	Elevating leg rests, pair (for use with capped rental wheelchair base)	Y	N/R	13	$97

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	71	$1,694	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for William S. Jonas, M.D.?

Tedicare shows public-source Medicare data for William S. Jonas, M.D. (NPI 1962443051), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William S. Jonas, M.D. have ACO affiliation data?

William S. Jonas, M.D. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to William S. Jonas, M.D.?

William S. Jonas, M.D. is linked to PIEDMONT CANCER INSTITUTE PC (billing NPI 1336180637) in the available physician profile data.

Does William S. Jonas, M.D. have Open Payments data?

William S. Jonas, M.D. has 71 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.